GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » Return-on-Tangible-Asset

Biovica International AB (OSTO:BIOVIC B) Return-on-Tangible-Asset : -112.19% (As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Biovica International AB's annualized Net Income for the quarter that ended in Jan. 2024 was kr-109.37 Mil. Biovica International AB's average total tangible assets for the quarter that ended in Jan. 2024 was kr97.49 Mil. Therefore, Biovica International AB's annualized Return-on-Tangible-Asset for the quarter that ended in Jan. 2024 was -112.19%.

The historical rank and industry rank for Biovica International AB's Return-on-Tangible-Asset or its related term are showing as below:

OSTO:BIOVIC B' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -297.55   Med: -61.64   Max: -31.36
Current: -103.42

During the past 9 years, Biovica International AB's highest Return-on-Tangible-Asset was -31.36%. The lowest was -297.55%. And the median was -61.64%.

OSTO:BIOVIC B's Return-on-Tangible-Asset is ranked worse than
79.82% of 1546 companies
in the Biotechnology industry
Industry Median: -40.335 vs OSTO:BIOVIC B: -103.42

Biovica International AB Return-on-Tangible-Asset Historical Data

The historical data trend for Biovica International AB's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB Return-on-Tangible-Asset Chart

Biovica International AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only -61.64 -85.95 -39.81 -45.79 -89.78

Biovica International AB Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -97.10 -100.13 -110.63 -122.20 -112.19

Competitive Comparison of Biovica International AB's Return-on-Tangible-Asset

For the Biotechnology subindustry, Biovica International AB's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biovica International AB's Return-on-Tangible-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biovica International AB's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Biovica International AB's Return-on-Tangible-Asset falls into.



Biovica International AB Return-on-Tangible-Asset Calculation

Biovica International AB's annualized Return-on-Tangible-Asset for the fiscal year that ended in Apr. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Apr. 2023 )  (A: Apr. 2022 )(A: Apr. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Apr. 2023 )  (A: Apr. 2022 )(A: Apr. 2023 )
=-110.492/( (111.278+134.869)/ 2 )
=-110.492/123.0735
=-89.78 %

Biovica International AB's annualized Return-on-Tangible-Asset for the quarter that ended in Jan. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Jan. 2024 )  (Q: Oct. 2023 )(Q: Jan. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Jan. 2024 )  (Q: Oct. 2023 )(Q: Jan. 2024 )
=-109.372/( (69.711+125.263)/ 2 )
=-109.372/97.487
=-112.19 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Jan. 2024) net income data.


Biovica International AB  (OSTO:BIOVIC B) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Biovica International AB Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Biovica International AB's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Biovica International AB (OSTO:BIOVIC B) Business Description

Traded in Other Exchanges
Address
Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37
Biovica International AB is a biotech company. It develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments. Through collaboration with world- leading cancer institutes and pharmaceutical companies, it promotes the trend in healthcare for personalized treatment, with a primary focus on patient survival and benefits to society. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB (OSTO:BIOVIC B) Headlines

No Headlines